Compare CXM & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CXM | AORT |
|---|---|---|
| Founded | 2009 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2021 | 1993 |
| Metric | CXM | AORT |
|---|---|---|
| Price | $7.73 | $46.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $9.89 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 2.4M | 358.0K |
| Earning Date | 12-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 180.38 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $839,147,000.00 | $422,646,000.00 |
| Revenue This Year | $8.25 | $15.97 |
| Revenue Next Year | $3.44 | $10.96 |
| P/E Ratio | $18.19 | ★ N/A |
| Revenue Growth | 6.48 | ★ 9.81 |
| 52 Week Low | $6.75 | $21.97 |
| 52 Week High | $9.69 | $48.25 |
| Indicator | CXM | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 50.96 | 53.55 |
| Support Level | $7.61 | $45.41 |
| Resistance Level | $7.98 | $48.00 |
| Average True Range (ATR) | 0.18 | 1.43 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 18.33 | 64.81 |
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.